K

Kangji Medical Holdings Ltd
HKEX:9997

Watchlist Manager
Kangji Medical Holdings Ltd
HKEX:9997
Watchlist
Price: 6.46 HKD 1.41% Market Closed
Market Cap: 7.6B HKD
Have any thoughts about
Kangji Medical Holdings Ltd?
Write Note

Kangji Medical Holdings Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kangji Medical Holdings Ltd
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
K
Kangji Medical Holdings Ltd
HKEX:9997
Accrued Liabilities
ÂĄ33.7m
CAGR 3-Years
31%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Accrued Liabilities
ÂĄ93.5m
CAGR 3-Years
36%
CAGR 5-Years
11%
CAGR 10-Years
26%
Autobio Diagnostics Co Ltd
SSE:603658
Accrued Liabilities
ÂĄ108.2m
CAGR 3-Years
33%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Accrued Liabilities
ÂĄ478.1m
CAGR 3-Years
19%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Accrued Liabilities
ÂĄ185m
CAGR 3-Years
18%
CAGR 5-Years
22%
CAGR 10-Years
N/A
No Stocks Found

Kangji Medical Holdings Ltd
Glance View

Market Cap
7.8B HKD
Industry
Health Care

Kangji Medical Holdings Ltd., nestled in the bustling backdrop of China's thriving medical device industry, has carved a niche for itself in the realm of minimally invasive surgery (MIS). Since its inception, the company has focused on designing and manufacturing a range of surgical tools and devices that cater specifically to MIS procedures. These procedures, which include general surgery, gynecology, and urology, are gaining popularity due to their reduced recovery times and lower risk factors compared to traditional surgery. Kangji Medical leverages its robust R&D capabilities and intimate understanding of physicians' needs to deliver high-quality, ergonomic instruments that enhance operational precision and patient outcomes. The lifeblood of Kangji Medical lies in its strategic manufacturing and marketing prowess, enabling it to maintain a solid foothold in the competitive landscape. By keeping its production chain streamlined and efficient, the company achieves significant cost advantages, which in turn translates to competitive pricing. These savings are reinvested in expanding its product portfolio and enhancing technological innovations, thus ensuring a constant edge over its peers. Moreover, Kangji's astute distribution networks and partnerships with leading hospitals enable it to secure a steady demand flow for its products. This strategy has not only facilitated steady revenue growth but also ensured Kangji's reputation as a reliable contributor to the advancing field of minimally invasive surgical procedures.

Intrinsic Value
10.28 HKD
Undervaluation 37%
Intrinsic Value
Price
K

See Also

What is Kangji Medical Holdings Ltd's Accrued Liabilities?
Accrued Liabilities
33.7m CNY

Based on the financial report for Dec 31, 2023, Kangji Medical Holdings Ltd's Accrued Liabilities amounts to 33.7m CNY.

What is Kangji Medical Holdings Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
16%

Over the last year, the Accrued Liabilities growth was 19%. The average annual Accrued Liabilities growth rates for Kangji Medical Holdings Ltd have been 31% over the past three years , 16% over the past five years .

Back to Top